Skip to content
The Omicron variant of the coronavirus puts the world on edge;  United States detects first case

Dr Stephen Hoge, president of Moderna, expressed hope that the pharmaceutical company’s Covid-19 vaccine would offer the “greatest efficacy” against the Omicron variant.

“Our hope, at least at Moderna, is that we’re going to continue to see the greatest overall efficiency and continue to see boosters grow even higher,” he said during CNN mayor tonight.

“The optimist in me looks like we might find in the next few weeks, as we generate more data in the real world, that vaccines hold up quite well,” he said.

Hoge was responding on Tuesday to remarks from Moderna CEO Stéphane Bancel in which he suggested that current vaccines may have difficulty with Omicron.

“There are no people, I think, where [the effectiveness] is of the same level. . . we had with [the] Delta [variant]”Bancel said in an interview with the Financial Times.” I think it’s going to be a big drop. I don’t know how much because we have to wait for the data. But all the scientists I’ve talked to … tell me, ‘It’s not going to be good.’ “

Hoge took issue with Bancel’s choice of word, but acknowledged this evening that current vaccines are likely to be less effective against Omicron.

“I think some of the word choices may not have been optimal,” Hoge told CNN’s Dr. Sanjay Gupta. “But I think what Stéphane Bancel was trying to say was consistent with what he said – and what we’re feeling, that is, it seems likely that the Omicron variant will reduce the effectiveness of our vaccine. In fact, in all of the vaccine’s effectiveness. “

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.